Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingyan drop pill case registration study for pharyngodynia
ChiCTR2100044677Phase 4Recruiting
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Mar 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Qingyan Dripping Pills in acute pharyngitis, chronic pharyngitis, acute tonsillitis and 2 more, sponsored by Beijing University of Chinese Medicine. Primary endpoint: Therapeutic effect and clinical characteristics for pharyngodynia. Started Mar 2021; status: recruiting.
02
Drugs
Qingyan Dripping Pills
03
Conditions
acute pharyngitischronic pharyngitisacute tonsillitisnasopharyngitispharyngitis
Beyond the preview
Go deeper on ChiCTR2100044677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044677.